chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm swollen; hot and red.; still is very warm; little pain, but no itching.; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swollen), ERYTHEMA (hot and red.), INJECTION SITE WARMTH (still is very warm) and PAIN (little pain, but no itching.) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm swollen), ERYTHEMA (hot and red.), INJECTION SITE WARMTH (still is very warm) and PAIN (little pain, but no itching.). At the time of the report, PERIPHERAL SWELLING (arm swollen), ERYTHEMA (hot and red.) and PAIN (little pain, but no itching.) had not resolved and INJECTION SITE WARMTH (still is very warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is getting Radiation and hormonal treatment for breast cancer. Also patient takes blood pressure medications.
pain at injection site; headache; achy/under arm sore; really tired/Fatigue; Significantly worsened; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site), HEADACHE (headache), MYALGIA (achy/under arm sore), FATIGUE (really tired/Fatigue) and CONDITION AGGRAVATED (Significantly worsened) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939909 and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at injection site), HEADACHE (headache), MYALGIA (achy/under arm sore), FATIGUE (really tired/Fatigue) and CONDITION AGGRAVATED (Significantly worsened). At the time of the report, VACCINATION SITE PAIN (pain at injection site), HEADACHE (headache), MYALGIA (achy/under arm sore), FATIGUE (really tired/Fatigue) and CONDITION AGGRAVATED (Significantly worsened) outcome was unknown.            Concomitant medications were not reported. Treatment details not reported. 2 lot no. was reported for first dose of moderna   This case was linked to MOD-2021-395714, MOD-2021-395738 (Patient Link).
FELT NAUSEOUS; This spontaneous report received from a consumer concerned a 56 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to gluten, and migraines, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medications included ondansetron for associated nausea, and sumatriptan for migraines. On 09-APR-2021, the subject experienced felt nauseous. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from felt nauseous. This report was non-serious.
Tested positive for COVID-19 two months after vaccination; Felt congested with a sore throat; Called doctor and was prescribed PAXLOVID.
2 days after immunization, developed red rash warm to touch involving anterior half of upper left arm circumferentially.
I received sore throat; fever; fatigue; cough; runny and stuffy nose; chills; body aches and I'm taking over the counter  Sudafed.  I still have symptoms.
Injection site red and swollen starting 3rd day; Injection site red and swollen starting 3rd day; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8733) via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 as a single dose for COVID-19 immunisation. No relevant medical history. The patient did not have any allergies to food, medications, or other products. . The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6206) via an unspecified route of administration in the left arm on 11Mar2021 at 16:30 as a single dose for COVID-19 immunisation. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 03Apr2021 at 17:00, the patient experienced injection site red(vaccination site erythema) and swollen(vaccination site swelling) starting 3rd day. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events injection site red (vaccination site erythema) and swollen(vaccination site swelling) starting 3rd day was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
I had severe pain in my back on the left side that radiated down to my backside that caused my leg to give out. I made an appointment to go see a chiropractor to find out if I had a pinched nerve, bulging disc anything that may be causing this issue. I had electric tens pulsating massage to help relax my muscles, an adjustment to bones to align them. I am feeling much better I do not feel that shooting pain. I am on the road to recovery.
patient with lymphedema and hives after receiving the COVID Vaccine, lasting weeks, of note patient had similar symptoms when she had COVID
Patient received first dose of Pfizer COVID vaccine on 3/17/21.  Around 3/19 or 3/20, patient started to feel fatigued with nausea, vomiting and diarrhea. He also developed fever, cough, and shortness of breath. He presented to the ER on 3/22 and was admitted to the hospital for supportive care and monitoring. Agency service was conuslted, and patient was started on COVID treatment with remdesivir and dexamethasone, and well as enoxaparin for VTE prophylaxis on 3/24.
No additional AE reported; Patient was administered improperly stored PEDVAXHIB;; This spontaneous report was received from a Medical Assistant referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reaction/allergies were not reported.   On 21-FEB-2022, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose and route were not reported; lot # U024089, expiration date: 27-OCT-2023) for prophylaxis (product storage error).    It was reported that the suspect vaccine was exposed to a temperature of minus 59.0 Fahrenheit (F) for a time frame of 2 hours and 47 minutes (the temperature excursion occurred on 19-FEB-2022). There were no previous temperature excursions.   No additional adverse event (AE) information was provided (no adverse event).
9-19-18 Noticed swelling at injection site and felt dizzy at 6 pm. 9-19-18 9pm felt dizzy, difficulty breathing so took a BENADRYL. 9-20-18 went to an urgent care for fever, cough, swelling at injection site where she got her flu shot. The urgent care told her to put ice to her arm, BENADRYL, ADVIL and rest. Discharge instruction stated localized reaction to flu shot. D/c to home.
Myalgia & Fever Narrative: dose 2-day 2- fever ; bodyache; sore shoulder at inj site
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 58-year-old male patient received BNT162b2 (BNT162B2), on 13Apr2022 as dose number unknown, single (Lot number: Fj4989) at the age of 58 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative, notes: Became antigen test negative; (unspecified date) Positive, notes: positive testing again; (06Jun2022) Positive, notes: positive testing again. Therapeutic measures were taken as a result of drug ineffective, covid-19. treatment received was no, known allergies was no.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the information available and close temporal association, a possible contributory role of the suspect Product cannot be excluded for the reported events . The case will be reassessed once new information is available.
About 5-7 min p/shot completed pt slumped over on the floor (from sitting position) arms & legs became very rigid & hands were curled up, lasted about 2-3 seconds; very pale & slightly diaphoretic, sz occurred;
No adverse effects reported; one expired dose of VAQTA was administered to an unspecified patient; This spontaneous report was received from a registered nurse concerning to a unspecified patient of unknown age and gender. The patient's historical conditions, previous drug reactions, allergies, concurrent condition and concomitant medications were not provided.    On 31-MAY-2019, the patient was vaccinated with one expired dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided) (route of administration was not reported, lot # R006342 and expiration date 21-APR-2019) for prophylaxis. No adverse effects reported.   This case is considered non-valid, as no patient identifiers were provided.  Lot number and expiration date were reported in the source document. But, when entering the lot number in the system automatically auto-populated the correct expiration date, which sometimes  may differs from the expiration date reported by the source.
On 5/7/19 at 1800, report from parent the L upper thigh was swollen, red and warm to touch.  Benadryl and Ibuprofen given.  On visit on 5/8/19 at 8:20am, report was lesions 5cm x 4.5 cm oblong erythematous with hardened center . 3cm round ; non tender and no drainage.
Next day couldn?t lift arm for day and a half (or put it all the way down). Three days later severe leg cramp that resulted in difficulty walking on it for two days. Then jaw was excruciating pain 5 days after?followed by 10 days of gum swelling, white spots on gums that hurt and couldn?t eat because of pain and swelling.
Rash on head potential shingles -  patient given zoster vaccine despite the potential viral infection.  Patient returned 2 more times in 3 days before being told there was nothing more they could do.  Patient presented at ED on June 30th for shingles diagnosis and pain management.
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Systemic: Abdominal Pain-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Severe, Additional Details: decreased perfussion to feet,legs, ankles and feet were slighly discolored blue due to decreased perfussion
14 MIN 30 SECONDS  AFTER THE INJECTION I FELT A SLIGHT TICKLE ON THE LEFT SIDE OF MY THROAT AND THEN FELT LIKE MY LEFT EAR WAS VERY WARM.  MY LT EAR TURNED BRIGHT RED AND I DID DEVELOPE A FEW SCATTERED HIVES TO MY UPPER CHEST, LT ARM, AND A FEW ON MY NECK.  I WAS GIVEN 25MNG OF BENADRYL AS WELL AS 20 MG OF PEPCID.   AT 30 MINUTES POST INJECTION MOST HIVES WERE GONE, EAR WAS NO LONGER RED AND I HAD NO OTHER REACTION .
12 hours afterward, pain at site of vaccine. 36 hours later severe pain, diffuse myalgias, fever, chills, nausea and vomiting.
That night I was ok- I woke up a little wet so I thought I must have had a fever but I was ok.   Then around 1:15 I started getting tired and then I started vomiting and then I went into cardiac arrest.  The 2nd dose kept me in bed for 2 days with flu like symptoms so I was expecting that. But this time my heart stopped
AS PER PATIENT, SHE STARTED GETTING HER ARM SORE NEXT DAY AFTER VACCINATION(09/05/18). AFTER 2 DAYS OF VACCINATION SHE DEVELOPED RASH AROUND SITE OF INJECTION AND WENT TO NURSER PRACTITIONER AND NP DIAGNOSED THAT ITS INFECTION AND GAVE HER ANTIBIOTIC. ON 09/08/18 PATIENT REPORTED THAT RASH IS GOING AWAY AND NO PAIN.
Came into the Health Department on 10/28/13 and was given an influenza and a pneumonia vaccine. Patient stated that after receiving his immunizations, that night he had a fever of 100.4F that last less than 24 hours. Patient complained on tenderness at injection site also. Patients stated that on the morning of 10/30/13 he noticed his left upper arm was red and warm to the touch. The redness started at the injection site and spread to the inside of his left upper arm. Patient stated he followed up with his doctor, on 10/30/13. Patient stated his doctor asked if he was allergic to eggs - patient denied an egg allergy. Patient stated administered a cortisone injection in 10/30/13. Patient stated that since injection was given, redness is lighting in color and left upper arm is no longer warm to the touch. Patient stated Dr. was not sure what had caused the reaction, since the patient has had the influenza vaccine and pneumonia vaccine in the past.
Not resistant; This case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a adult female patient who received HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received Engerix B at an unknown dose. On an unknown date, unknown after receiving Engerix B, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown.   It was unknown if the reporter considered the therapy non-responder to be related to Engerix B.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient received the Hepatitis-B series as a child and was not Hepatitis-B resistant. The reporter mentioned that the patient heard that the vaccines from the 90's were not resistant and need to repeat the series. The patient started rotation in a month, and would like to know what are her choices. The reporter was unsure whether the Hepatitis-B vaccine given was Engerix-b or not. No additional information was provided.      Lab Comments: On an unknown date lab test was performed
Client is 17 years of age, Moderna has not been authorized for use in those under 18 years of age. The administration error was not discovered until client presented for 2nd dose, the nurse reviewed the consent prior and the age of the client was found to be 17 years old. The 2nd dose was not given. Client did not report any adverse symptoms from the first dose.
Still have a running nose; Watery eye; Kind of profusing; Have been sneezing; Nose just runs constantly; One of his eyes keeps tearing; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Still have a running nose), LACRIMATION INCREASED (Watery eye), IRRITABILITY (Kind of profusing), SNEEZING (Have been sneezing) and RHINORRHOEA (Nose just runs constantly) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy. Concomitant products included ATORVASTATIN, OMEPRAZOLE, FAMOTIDINE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced RHINORRHOEA (Still have a running nose), LACRIMATION INCREASED (Watery eye), IRRITABILITY (Kind of profusing), SNEEZING (Have been sneezing), RHINORRHOEA (Nose just runs constantly) and LACRIMATION INCREASED (One of his eyes keeps tearing). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Still have a running nose), LACRIMATION INCREASED (Watery eye), IRRITABILITY (Kind of profusing), SNEEZING (Have been sneezing), RHINORRHOEA (Nose just runs constantly) and LACRIMATION INCREASED (One of his eyes keeps tearing) had resolved.            The patient received second dose of the Moderna vaccine on the day of reporting and began to have symptoms from that day onwards. The patient took a Claritin, but it did not help. The patient also reported that they had seasonal allergies, but on the first dose did not have any symptoms.  On 16-Jul-2021, the patient reported that their running nose, watery eye, kind of perfusing, nose just runs constantly, sneezing, and one of their eyes keeps tearing, all these symptoms subsided after two weeks of second dose. Reportedly, the patient sneezed occasionally, and their nose was still dripping but not like it did back then. The patient's sneeze subsided a lot, but the patient was having seasonal allergies for a long time.   This case was linked to US-MODERNATX, INC.-MOD-2021-068287 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow-up was received. Updated outcome of all the events reported. Updated the treatment medication in the products tab.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068287:1st dose
One of the patient's arms was injured; Case reference number US-BN-2023-000194 is a spontaneous case report initially received from other health care professional via Communication (reference number: USBAV23-0208) on 06-Feb-2023 and concerns a female patient of unknown age.  The patient's relevant medical history and concomitant medication details were not provided.  On unspecified dates, the patient was vaccinated with the first, second dose and third dose of RabAvert vaccine (rabies virus (inactivated, strain flury lep) (pcec); batch number: not provided) at an unknown dose, site or route of administration for rabies pre or post prophylaxis.   On an unspecified date, an unknown amount of time after the first dose of RabAvert, the patient experienced injury on one of the arms.   At the time of the initial report, the outcome of the event 'limb injury' was unknown.   The reporter did not provide seriousness or causality assessment.   Additional information received on 07-Feb-2023 included local case ID.; Reporter's Comments: A female patient of unknown age experienced a non-serious event of injury on one of the arms, on an unspecified date, an unknown amount of time after the patient was vaccinated with the first, second dose and third dose of RabAvert vaccine, at an unknown dose, site or route of administration for rabies pre or post prophylaxis. Limb injury is unlisted for RabAvert according to the guidelines. The patient's relevant medical history and concomitant medication details were not provided. The outcome was unknown. Since the evaluation did not find enough evidence to completely exclude a contributory role of the suspect vaccine to the development of the event, limb injury has been considered as related to RabAvert. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age experienced a non-serious event of injury on one of the arms, on an unspecified date, an unknown amount of time after the patient was vaccinated with the first, second dose and third dose of RabAvert vaccine, at an unknown dose, site or route of administration for rabies pre or post prophylaxis. Limb injury is unlisted for RabAvert according to the guidelines. The patient's relevant medical history and concomitant medication details were not provided. The outcome was unknown. Since the evaluation did not find enough evidence to completely exclude a contributory role of the suspect vaccine to the development of the event, limb injury has been considered as related to RabAvert. This case is considered as non-serious.
Post vx, no reaction for 4-5 da. Next 10 da., noticeable itching @vx site. Scab for 25 days, then part fell off w/removal of gauze. Scab reappeared w/in 3-4 da. on 48th da. scab came off in shower. No other side effects except pt. occasionally tired.
I did not have an adverse reaction to the vaccine. I tested positive for COVIDD-19 in 04/2023. I had a very runny nose, loss of appetite, diarrhea, fatigue and sore throat. I contacted my doctor, and I got a prescription for Paxlovid. I had not complications taking the medication. As of today, I am feeling better, but I still have a runny nose.
5 days after receiving the vaccine I started with terrible gas. By the next day I had a headache, diarrhea, abdominal pain, body aches. Also developed an itchy rash/hive at the injection site. It is now 5 days later and I am still not 100%.
headache; jabs on her face; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (jabs on her face) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Trigeminal neuralgia (Patient had Trigeminal Neuralgia and says that it had been under control with her medications,).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FACIAL PAIN (jabs on her face). On 07-Mar-2021, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN for Headache and Neuralgia, at a dose of 1 dosage form and CARBAMAZEPINE for Neuralgia, at a dose of 1 dosage form. On 16-Mar-2021, FACIAL PAIN (jabs on her face) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication include diuretic as blood pressure medication.  Patient gave consent for safety to Follow-up.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up information was received and outcome of event pain in face was updated as recovered.
repeated vomiting over 24 hour period, muscle pain, weakness to the point of needing assistance to get to the bathroom
swelling of tongue and left side of lip, benadryl. lasted 10hr, swelling has decreased